<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=4423596&amp;fmt=gif">
New fill/finish partnership with BioConnection provides end-to-end drug product development under 1 contract!   Read the press release
On-demand webinar:

Developing A Gene Therapy Strategy that Navigates Economic Challenges & Regulatory Changes

Learn about: 

  • Managing funding and resources in a capital-strapped industry

  • Major manufacturing and analytical pitfalls

  • Producing a gene therapy that is scalable and reproducible

  • Top regulatory hurdles you should look to avoid

Webinar overview: 

Our panel of industry experts offers strategies and advice for gene therapy businesses amidst financial and regulatory changes. Watch and get insights into how to better manage strategic business decisions, technology and platform implementations, scaling your product at each stage, and more.

Our Panel of Industry Experts

Click on the speaker photos to read their bios

Scott Cross headshot

Scott Cross

Senior Principal Head of Gene Therapy CMC, Dark Horse Consulting
paola pozzi headshot-small

Paola Pozzi

Partner, Sofinnova Telethon Strategy
miguel forte headshot

Miguel Forte

President, International Society for Cell & Gene Therapy

Experts from our Milan Cell & Gene Center of Excellence

Click on the photos to read their bios


Luca Alberici

Site Head of Milan Facility, AGC Biologics
Giuliana Vallanti headshot

Giuliana Vallanti

VP, Development and Global R&D C&G, AGC Biologics

Additional Cell & Gene Therapy

Educational Content

Like a Tailored Suit download graphic no iconBuilding Customized Viral Vector Programs

Access white paper

Outsourcing Allogeneic Cell Therapy - download graphic no iconAccelerating Allogeneic Cell Therapies 

Access white paper

large-scale aav manufacturing download graphic no iconCreating a Large-Scale AAV Platform

Access white paper